KLF5 promotes apoptosis induced by phorbol ester as an effector of the autocrine factor TNFα in LNCaP prostate cancer cells

Por Shi, Qi, Jia, Jing, Hui, Ke, Gao, Yang, Xu, Shan, Guan, Bing, Tang, Xiaoshuang, Wang, Xinyang, He, Dalin, Guo, Peng
Publicado no Oncol Lett (2017)

Beyond proliferation: KLF5 promotes angiogenesis of bladder cancer through directly regulating VEGFA transcription

Por Gao, Yang, Wu, Kaijie, Chen, Yule, Zhou, Jiancheng, Du, Chong, Shi, Qi, Xu, Shan, Jia, Jing, Tang, Xiaoshuang, Li, Feng, Hui, Ke, He, Dalin, Guo, Peng
Publicado no Oncotarget (2015)

RASAL2, a RAS GTPase-activating protein, inhibits stemness and epithelial–mesenchymal transition via MAPK/SOX2 pathway in bladder cancer

Por Hui, Ke, Gao, Yang, Huang, Jun, Xu, Shan, Wang, Bin, Zeng, Jin, Fan, Jinhai, Wang, Xinyang, Yue, Yangyang, Wu, Shiqi, Hsieh, Jer-Tsong, He, Dalin, Wu, Kaijie
Publicado no Cell Death Dis (2017)

KLF4 K409Q –mutated meningiomas show enhanced hypoxia signaling and respond to mTORC1 inhibitor treatment

Por Niklas von Spreckelsen, Natalie Waldt, Rebecca Poetschke, Christoph Kesseler, Hildegard Dohmen, Hui-Ke Jiao, Attila Nemeth, Stefan Schob, Cordula Scherlach, Ibrahim Erol Sandalcioglu, Martina Deckert, Frank Angenstein, Boris Krischek, Pantelis Stavrinou, Marco Timmer, Marc Remke, Elmar Kirches, Roland Goldbrunner, E. Antonio Chiocca, Stefan Huettelmaier, Till Acker, Christian Mawrin
Publicado em 2020-04-01